Independent Advisor Alliance Invitae Corp Transaction History

Independent Advisor Alliance

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$2.13 - $9.01 $24,000 - $101,524	-11,268 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$6.28 - $15.59 $10,274 - $25,505	-1,636 Reduced 12.68%	11,268 $90,000
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $21,697 - $42,316	-1,476 Reduced 10.26%	12,904 $197,000
Q3 2021 Nov 01, 2021	SELL	$24.31 - $33.6 $12,446 - $17,203	-512 Reduced 3.44%	14,380 $409,000
Q2 2021 Aug 12, 2021	BUY	$26.09 - $40.4 $7,566 - $11,716	290 Added 1.99%	14,892 $502,000

Q1 2021 May 14, 2021	SELL	$33.06 - $56.93 $6,049 - $10,418	-183 Reduced 1.24%	14,602 $558,000
Q4 2020 Feb 11, 2021	BUY	$39.09 - $57.4 $41,630 - $61,131	1,065 Added 7.76%	14,785 $618,000
Q3 2020 Nov 04, 2020	SELL	$28.43 - $44.67 $204,553 - $321,400	-7,195 Reduced 34.4%	13,720 $595,000
Q2 2020 Aug 06, 2020	BUY	$11.71 - $30.29 $244,914 - $633,515	20,915 New	20,915 $634,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

Stay updated on Independent Advisor Alliance with notifications on news.